Compensated Awareness Post View
Disclaimer
$CWNM Our Executive and Scientific Team
The Crown Marketing Pharmaceuticals management team is headed by seasoned CEO Learned Hand, and is supported by a strong Scientific Advisory Board. Mr. Hand has been an executive in the pharmaceutical industry for more than a decade. The former Vice President and Chief Operating Officer of Warren Pharmaceuticals, Inc, Mr. Hand was an integral part of Warren’s founding and launch, serving with the company from 2000 to 2003. During Mr. Hand’s time with the company, Warren Pharmaceuticals pioneered the discovery and development of a novel therapeutic class of protein-based drugs called Tissue-Protective Cytokines, or TPCs. TPCs have potent protective effects that diminish and reverse the underlying cellular damage common to many significant diseases, and TPCs have the potential to treat such devastating illnesses and injuries as stroke, heart attack, spinal cord injury, acute muscular edema, and acute kidney failure. The biological activities of TPCs are transduced through a novel tissue protective cytokine receptor identified by Warren scientists. Warren has licensed the worldwide development and commercialization rights to the central and peripheral nervous system indications of its TPCs other than ophthalmic and diabetes to the Danish pharmaceutical company H. Lundbeck A/S.
